ICER for postpolicy relative to prepolicy in acute coronary syndrome patients 1 year after percutaneous coronary intervention
| Implementation of coronary stent policies | Total medical cost (thousand ¥) | Incremental cost (thousand ¥) | Number of MACEs prevented | Incremental effectiveness (number of MACEs prevented) | ICER |
| Based on real-world data | |||||
| Postpolicy | 6 142 960.83 | −1 980 514.44 | 81 670 | 1750 | −1131.72 |
| Prepolicy | 8 123 475.28 | 79 920 | |||
| Based on PS-matched data | |||||
| Postpolicy | 6 381 653.22 | −1 827 147.76 | 81 850 | 2170 | −842.00 |
| Prepolicy | 8 208 800.99 | 79 680 | |||
ICER, incremental cost-effectiveness ratio; MACEs, major adverse cardiac events; PS, propensity score.